Catalyst Pharmaceuticals, Inc.CPRXNASDAQ

Revenue (LTM)

$589M

+19.8% YoY

Net Income (LTM)

$214M

+30.8% YoY

Free Cash Flow

$209M

Revenue CAGR (5Y)

+37.7%

—Marginsstable

FCF$0.2B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	141	214↑52.1%	398↑85.9%	492↑23.5%	589↑19.8%
Gross Profit	119	180↑51.2%	346↑92.6%	423↑22.1%	502↑18.6%
Operating Income	52	102↑94.4%	87↓14.8%	195↑124.8%	258↑32.1%
Net Income	39	83↑110.4%	71↓14.0%	164↑129.5%	214↑30.8%
EBITDA	53	103↑96.0%	120↑16.1%	233↑94.6%	321↑37.8%
EPS Diluted	0.37	0.75↑102.7%	0.63↓16.0%	1.31↑107.9%	1.68↑28.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	171	298↑74.0%	138↓53.9%	518↑276.0%	709↑37.0%
Total Current Assets	210	321↑52.7%	219↓31.6%	624↑184.3%	894↑43.4%
Total Assets	238	376↑58.0%	470↑25.2%	851↑81.1%	1,107↑30.0%
Total Current Liabilities	27	58↑112.8%	76↑32.1%	121↑58.7%	147↑21.9%
Total Liabilities	31	75↑142.9%	82↑9.3%	124↑50.5%	153↑23.2%
Total Equity	207	300↑45.2%	388↑29.1%	728↑87.6%	954↑31.1%
Total Debt	4	4↓7.3%	4↓8.7%	3↓10.4%	3↓12.6%
Net Debt	-167	-295↓76.1%	-134↑54.5%	-514↓283.6%	-706↓37.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	60	116↑92.2%	144↑23.7%	240↑67.0%	209↓13.0%
Capital Expenditure	-1	-0↑97.2%	-82↓281775.9%	-1↑99.3%	-0↑89.6%
Free Cash Flow	59	116↑95.5%	62↓46.7%	239↑286.8%	209↓12.8%
Stock-Based Comp	6	8↑30.2%	14↑80.2%	22↑56.1%	25↑11.4%
Net Change in Cash	41	127↑208.1%	-161↓226.6%	380↑336.3%	192↓49.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance